Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
about
Two conformational states in the crystal structure of the Homo sapiens cytoplasmic ribosomal decoding A site.Antibiotics that target protein synthesisStructural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics.A Steric Block in Translation Caused by the Antibiotic SpectinomycinAllosteric control of the ribosome by small-molecule antibiotics.A structural basis for the antibiotic resistance conferred by an A1408G mutation in 16S rRNA and for the antiprotozoal activity of aminoglycosidesThe Impact of Aminoglycosides on the Dynamics of Translation ElongationSelectivity of stop codon recognition in translation termination is modulated by multiple conformations of GTS loop in eRF14′-O-substitutions determine selectivity of aminoglycoside antibioticsThe ribosome-bound chaperones RAC and Ssb1/2p are required for accurate translation in Saccharomyces cerevisiae.Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistanceDetermination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection modelA novel role of cytosolic protein synthesis inhibition in aminoglycoside ototoxicity.Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity.Aminoglycoside activity observed on single pre-translocation ribosome complexes.Structures and stabilization of kinetoplastid-specific split rRNAs revealed by comparing leishmanial and human ribosomesThe unfolded protein response affects readthrough of premature termination codonsCorrection of genetic disease by making sense from nonsense.A mutation in the decoding center of Thermus thermophilus 16S rRNA suggests a novel mechanism of streptomycin resistance.Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.Evidence of efficient stop codon readthrough in four mammalian genesA comprehensive analysis of translational missense errors in the yeast Saccharomyces cerevisiae.Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.Identification and evaluation of improved 4'-O-(alkyl) 4,5-disubstituted 2-deoxystreptamines as next-generation aminoglycoside antibiotics.Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi.Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation systemAntibiotic selectivity for prokaryotic vs. eukaryotic decoding sites.Genomic analysis reveals distinct concentration-dependent evolutionary trajectories for antibiotic resistance in Escherichia coli.Role of 16S rRNA Helix 44 in Ribosomal Resistance to Hygromycin BPlasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylationSuppression of nonsense mutations as a therapeutic approach to treat genetic diseases.RNA-seq analysis of the effect of kanamycin and the ABC transporter AtWBC19 on Arabidopsis thaliana seedlings reveals changes in metal content.Chemically related 4,5-linked aminoglycoside antibiotics drive subunit rotation in opposite directionsActivation of the dormant secondary metabolite production by introducing gentamicin-resistance in a marine-derived Penicillium purpurogenum G592-Deoxystreptamine Conjugates by Truncation-Derivatization of NeomycinEngineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteriaSuppression of premature termination codons as a therapeutic approach.Direct observation of aminoglycoside-RNA binding by localized surface plasmon resonance spectroscopy.Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.
P2860
Q25255922-ABA313B3-EBEB-4EFE-809D-D65C06ED170CQ27025271-02143687-4DC8-45A8-BB87-E43EC7CA221AQ27621003-729888D0-2C69-4C88-8651-F0C84C8501FBQ27647153-B854DE52-F315-4D53-B188-29EBEED01B2FQ27671570-150B064A-0A8B-4B38-AD15-C3B0356E74CEQ27675767-183EC363-A36E-4653-AD5E-6D1783C0D125Q27676402-89FED67B-372E-4513-BEA4-357C69E80266Q27677568-2B8CF002-A90C-4592-910F-C956F68A3CC3Q27681495-0D036AB9-DCF6-4821-93F5-1F68823020E7Q27937098-B6B38A24-4C2E-4D83-BF54-83F839C01D70Q28138065-28756D8B-97A5-4A8F-A45F-62602BA4D8ECQ28474000-2385FCC6-0CF8-4EBB-BB63-5EBDE1874AFEQ30417680-BF710852-F854-430C-8E3F-01B60ABB7442Q30488706-FBE14BFF-A704-42C7-9246-925EA283818BQ30495847-DAA864E6-1C47-411C-880D-1CD397A4DABAQ30824903-49E8FBA9-45F0-4A98-9285-F8EF86AC0828Q33623379-73A0A9B5-7336-4F21-9692-58DB77AD81AEQ33712661-ECC62670-2B12-4D1E-8728-6C7CAF5B230CQ33714625-F27C3224-8776-4EE1-9C22-5FB3BE3CD878Q33826477-696A4263-E941-4E9A-A1D1-75E43613FDE6Q33876486-D9D72C28-0958-4078-BBF7-3285104EDBC7Q34044340-836A65AA-89C0-4AA5-86EC-A1BAB3D066E1Q34075919-DD93F41E-F365-47E1-A6AE-E6BD90AE7376Q34269044-A0C1C8B8-2CAC-4374-8362-2F458F2BC4AAQ34334742-3BEB6DF1-1F0F-4A3C-9562-62C05044FF5BQ34352235-3946137E-E0D0-4088-B8B3-6C2A6D9BED2EQ34362841-5E8A1187-35D5-4A59-8C6C-B0D40BC07FE5Q34559498-95F85B6B-902C-4AFC-B8EB-E864FFE90583Q34679062-BE33D865-3479-4457-AC32-CE67EA34F6A8Q34942162-4545C102-1BE0-40FC-A2F0-56F155D19D85Q35165835-812D2770-08A3-4736-A847-CBB9B243C8F0Q35287888-2E36F35F-2A2F-4A65-BB8F-83ACFA585A32Q35326720-6DE28C63-F689-4660-9703-4819146C95BBQ35909870-A65DC5AB-14F9-46FF-A61E-6FE87269A186Q35942623-6C5FFEA0-C878-4647-9BA3-9011AB3E2C20Q36155880-45BE644E-1D9E-4A5F-B9B9-5DC9C239D9F2Q36168675-F05D4BE6-201B-4099-B6A0-D11A21414095Q36203719-1FE0E8C8-51EA-4D35-9D7D-7930D7059E95Q36635841-5930228D-BE06-4857-9FDE-599037ECD664Q37050322-9EECC2DD-3068-4300-BA1F-8179C90733E3
P2860
Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Basis for prokaryotic specificity of action of aminoglycoside antibiotics
@nl
Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
@ast
Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
@en
type
label
Basis for prokaryotic specificity of action of aminoglycoside antibiotics
@nl
Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
@ast
Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
@en
prefLabel
Basis for prokaryotic specificity of action of aminoglycoside antibiotics
@nl
Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
@ast
Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
@en
P2860
P3181
P356
P1433
P1476
Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
@en
P2093
J D Puglisi
P2860
P304
P3181
P356
10.1093/EMBOJ/18.11.3133
P407
P577
1999-06-01T00:00:00Z